Essential Pharma

Greater London Legal Chronicle. February 16, 2024

Essential Pharma’s Acquisition of European Rights to Colobreathe

By Georgio Naffaa

In UK Taylor Wessing, advised on the matter. Taylor Wessing advised Essential Pharma with a team including Suzy Davis (Picture – Corporate M&A), Colin McCall (IP&IT),...

This content is for members only.
Join Now

Already a member? Log in here

Cleary Gottlieb’s Client, Banco Santander, Completes $1.25 Billion Notes Offering

Kirkland Advises KKR on $1.1 Billion Investment in Cvent

Amaroq Minerals’ £27.5 Million Fundraising

Kirkland Advises Blackstone on $1.5 Billion Investment in KKR

The Walt Disney Company’s $500 Million Senior Notes Offering

FirstGroup’s £500m Train Deal with Hitachi

Cicada Solar Limited’s $10 Million Financing Round

Coigach Community Development Company’s Acquisition Of 7,900 Acres Of Tenanted Croft Land And Common Grazings

Robert P. Slight & Sons’ Sale to EOT

RoundShield’s Closing of Private Credit Fund RS Fund V

Deep Blue’s Launch of the First Stablecoin of DBUSD in Jersey

Phoenix Equity Partners’ £200 Million Launch of Growth Partnership Fund

Stevens & Bolton Bolsters Corporate Tax Practice With Lateral Hire

Charles Russell Speechlys Announces the Opening of a New Office in Italy

TLT Appoints Madi Dacwy as a Partner In Its Projects, Infrastructure and Construction Team

Essential Pharma’s Acquisition of European Rights to Colobreathe